Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Reviews in Obstetrics & Gynecology|May 28, 2011
The impact of liquid-based cytology in decreasing the incidence of cervical cancerRandall K Gibb, Mark G Martens
Gynecologic Oncology|July 8, 2015
Teleoncology for gynecologic cancersDavid I Shalowitz, Allison G Smith, Maria C Bell, et al.
Gynecologic Oncology|July 21, 2004
The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro modelNeil S Horowitz, Jun Hua, Randall K Gibb, et al.
Anticancer Research|November 2, 2007
Bevacizumab therapy in patients with recurrent uterine neoplasmsJason D Wright, Matthew A Powell, Janet S Rader, et al.
Gynecologic Oncology|March 13, 2016
Prognostic impact of clinical tumor size on overall survival for subclassifying stages I and II vaginal cancer: A SEER analysisAaron H Wolfson, Isildinha M Reis, Lorraine Portelance, et al.
Gynecologic Oncology|November 16, 2010
Ovarian cancer patient surveillance after curative-intent initial treatmentGaro Z Harmandayan, Feng Gao, David G Mutch, et al.
Gynecologic Oncology|August 28, 2007
Novel cytotoxic agents from an unexpected source: bile acids and ovarian tumor apoptosisNeil S Horowitz, Jun Hua, Matthew A Powell, et al.
Obstetrics and Gynecology|April 30, 2002
Utility and cost-effectiveness of preoperative autologous blood donation in gynecologic and gynecologic oncology patientsNeil S Horowitz, Randall K Gibb, Nicole E Menegakis, et al.
Gynecologic Oncology|September 20, 2005
Defective DNA mismatch repair and XRCC2 mutation in uterine carcinosarcomasNicholas P Taylor, Randall K Gibb, Matthew A Powell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
Frequent HOXA11 and THBS2 promoter methylation, and a methylator phenotype in endometrial adenocarcinomaBradford P Whitcomb, David G Mutch, Thomas J Herzog, et al.
Pageof 5